Novo Holdings is a Danish private limited liability company wholly owned by the Novo Nordisk Foundation. Established in 1999, Novo Holdings is the holding company of the Novo Group and manages the Foundation’s investment assets.
In addition to being the major shareholder in the Novo Group companies, Novo Holdings invests the wealth of the Foundation in two key categories:
1. Life Science Investments, which includes investing in life science companies at all stages of development
2. Financial Investments, which manages equity and fixed income securities
Working out of Copenhagen, with affiliates in San Francisco and Boston, Novo Holdings is a life science investor that aims to grow the assets of the Foundation and to deliver a return that the Foundation can distribute for scientific, social and humanitarian purposes.
Timeline
Funded Companies
Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare.
A company developing Hypoxia Inducible Factor therapies to treat kidney diseases and other conditions
A New Zealand industrial biotechnology company developing a gas fermentation platform for converting concentrated industrial emissions into valuable chemicals.
Harmony Biosciences is a private biopharmaceutical company that develops and commercializes novel treatment options.
A clinical late-stage biopharmaceutical company in California that focuses on treatments of dermatologic conditions such as atopic dermatitis, psoriasis and prurigo nodularis.
Nkarta Therapeutics is a biotechnology company using natural killer (NK) immune cells for cellular therapies.
Nora Therapeutics is a specialty biopharmaceutical company developing therapeutics to address clinical unmet needs in reproductive medicine.
Bolt Biotherapeutics is developing its novel BoltbodyTM platform, a cancer immunotherapy that consists of Immune-Stimulating Antibody Conjugates (ISAC).
Vestaron is a Kalamazoo, Michigan-based agricultural technology company manufacturing bioinsecticides from naturally occurring peptides
A diagnostics company developing automated sample processing
Disc Medicine is a medical research company that develops treatments for hematologic diseases.
Edgewise Therapeutics is a drug discovery and biotechnology company developing products based on the understanding of skeletal muscle.
Cancer treatment company
Cyteir Therapeutics is a Cambridge, Massachusetts-based company.
Now Avalyn Pharma, a biopharmaceutical company developing therapies to treat idiopathic pulmonary fibrosis and other respiratory diseases
Lysogene is a company by Karen Aiach.
Tarsa Therapeutics is a Philadelphia County, Pennsylvania-based company.
A company that develops cell therapies to treat kidney diseases
Mirum Pharmaceuticals is a Menlo Park, California-based company.
Swift Health Systems dba INBRACE is an Irvine, California-based medical device company.
Morphic Therapeutic is a Waltham, Massachusetts-based company.
